The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Boris Schmidt
Showing 1-10 of 10 articles
Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study
Aminian A,
De Backer O,
Nielsen-Kudsk J,
Mazzone P,
Berti S,
Fischer S,
Lund J,
Montorfano M,
Lam S,
Freixa X,
Gage R,
Diener H,
Schmidt B
October 20, 2021 | 10.4244/EIJ-D-20-01309
Retrieval of embolised left atrial appendage closure devices
Kany S,
Bordignon S,
Piorkowski M,
Chen S,
Chun K,
Tohoku S,
Schmidt B
June 11, 2021 | 10.4244/EIJ-D-19-01088
Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry
Landmesser U,
Tondo C,
Camm J,
Diener H,
Paul V,
Schmidt B,
Settergren M,
Teiger E,
Nielsen-Kudsk J,
Hildick-Smith D
August 3, 2018 | 10.4244/EIJ-D-18-00344
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study
Bergmann M,
Ince H,
Kische S,
Schmitz T,
Meincke F,
Schmidt B,
Foley DP,
Betts TR,
Grygier M,
Protopopov A,
Stein KM,
Boersma L
April 20, 2018 | 10.4244/EIJ-D-17-00672
Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices
Weise FK,
Bordignon S,
Perrotta L,
Konstantinou A,
Bologna F,
Nagase T,
Chen S,
Chun K,
Schmidt B
April 6, 2018 | 10.4244/EIJ-D-17-00901
Carag bioresorbable septal occluder (CBSO): histopathology of experimental implants
Sigler M,
Söderberg B,
Schmidt B,
Mellmann A,
Bernhard J
February 20, 2018 | 10.4244/EIJ-D-17-00006
Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study
Landmesser U,
Schmidt B,
Nielsen-Kudsk J,
Chi Lam S,
Park J,
Tarantini G,
Cruz-González I,
Geist V,
Della Bella P,
Colombo A,
Zeus T,
Omran H,
Piorkowski M,
Lund J,
Tondo C,
Hildick-Smith D
September 20, 2017 | 10.4244/EIJ-D-17-00493
Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry
Bergmann M,
Betts TR,
Sievert H,
Schmidt B,
Pokushalov E,
Kische S,
Schmitz T,
Meincke F,
Stein KM,
Boersma L,
Ince H
September 20, 2017 | 10.4244/EIJ-D-17-00042
Percutaneous pulmonary valve replacement using completely tissue-engineered off-the-shelf heart valves: six-month in vivo functionality and matrix remodelling in sheep
Schmidt B,
Spriestersbach H,
h-Ici D,
Radtke T,
Bartosch M,
Peters H,
Sigler M,
Frese L,
Dijkman P,
Baaijens F,
Hoerstrup S,
Berger F
May 16, 2016 | 10.4244/EIJV12I1A12
Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach
Tzikas A,
Gafoor S,
Meerkin D,
Freixa X,
Cruz-González I,
Lewalter T,
Saw J,
Berti S,
Nielsen-Kudsk J,
Ibrahim R,
Lakkireddy D,
Paul V,
Arzamendi D,
Nietlispach F,
Worthley S,
Hildick-Smith D,
Thambo J-B,
Tondo C,
Aminian A,
Kalarus Z,
Schmidt B,
Søndergaard L,
Kefer J,
Meier B,
Park J,
Sievert H,
Omran H
April 20, 2016 | 10.4244/EIJV11I13A292
1
Latest news
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke